Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Pharmaceutical > Infectious Disease > Chinese Markets for Hepatitis Treatment Drugs
Category
Pharmaceutical (4993)
Bone Disease Treatment (46)
Cancer (884)
Diabetes (159)
Drug Delivery System (184)
Drug Discovery (1403)
Generic Drugs (128)
Infectious Disease (407)
Mental Disease (98)
Neurodegenerative Disease (180)
Obesity Treatment (49)
OTC Drug (149)
Pharmaceutical Companies (562)
Prescription Drugs (120)
Regulation (122)
Vaccines (178)
Veterinary Medicine (28)
Market Research Report

Chinese Markets for Hepatitis Treatment Drugs

Published by Asia Market Information & Development
Published June, 2009 Product code 91229
Content info 167 Pages
Price
US $ 4000 PDF by E-mail (Single User License)
US $ 8000 PDF by E-mail (Corporate Use License)


Chinese Markets for Hepatitis Treatment Drugs published by Asia Market Information & Development in June, 2009. This report consists of 167 Pages and the price starts from US $ 4000.

Introduction

Abstract

China' s demand for Hepatitis Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Table of Contents

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

  • Hepatitis Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Hepatitis Drugs Industry Sales Volumes
  • Major Producer Facility Locations and Sales Volumes
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

  • Overview
  • Sales Volumes of Hepatitis Drugs by Region in 2008
  • Hepatitis Drugs Sales Volumes
  • Liver Protection Drugs
  • Nucleoside Drugs
  • Interferon (IFN)
  • Other Hepatitis Drugs
  • Hepatitis Drugs Imports and Exports
  • Hepatitis Drugs Imports
  • Hepatitis Drugs Exports
  • Pricing Trend

V. HEPATITIS DRUGS MARKET OUTLOOK

  • Hepatitis Drugs Market Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China' s Distribution System
  • Hepatitis Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China' s Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. HEPATITIS DRUGS PRODUCER DIRECTORY

  • Hepatitis Drugs Producer Profiles

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

  • Hepatitis Drugs Industry Sales Volumes
  • Major Producer Facility Locations
  • Major Hepatitis Drugs Producer Sales Volumes
  • Market Share of Key Producers
  • Major Foreign Investments in China

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

  • Hepatitis Drugs Sales Volumes
  • Sales Volumes of Hepatitis Drugs by Region in 2008
  • Major Liver Protection Drugs Producer Sales Volumes
  • Liver Protection Drugs Sales Volumes
  • Major Nucleoside Drugs Producer Sales Volumes
  • Nucleoside Drugs Sales Volumes
  • Major IFN Drugs Producer Sales Volumes
  • Interferon (IFN) Sales Volumes
  • Other Hepatitis Drugs Sales Volumes
  • China Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK

  • Total hepatitis Drugs Sales Volumes by Market
  • Hepatitis Drugs Sales Volumes and Market Share in 2008
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • China' s Hepatitis Drugs Sales Volumes

II. BUSINESS ENVIRONMENT

  • China' s GDP and Growth Rate
  • Industrial Output by Ownership
  • China' s Imports and Exports

III. HEPATITIS DRUGS INDUSTRY ASSESSMENTS

  • Hepatitis Drugs Sales Volumes in China

IV. HEPATITIS DRUGS PRODUCTION AND DEMAND

  • Total Hepatitis Drugs Sales Volumes
  • Total Hepatitis Drugs Imports and Exports

V. HEPATITIS DRUGS MARKET OUTLOOK

  • Hepatitis Drugs Sales Volumes by Market in 2008

VI. MARKETING STRATEGIES

  • China' s Distribution Channel
Back to Top